Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lun Lu

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
Journal for Immunotherapy of Cancer|January 27, 2025
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinomaShin-Yi Chung, Yi-Chen Yeh, Chien-Jung Huang, et al.
Frontiers in Oncology|July 28, 2023
Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomyAnkit Potdar, Ke-Cheng Chen, Shuenn-Wen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancerSajni Josson, Murali Gururajan, Peizhen Hu, et al.
Stem Cell Research & Therapy|April 2, 2024
Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesiclesJing Wang, Zhong-Jin Chen, Ze-Yi Zhang, et al.
Hepatology International|September 6, 2019
Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysisChao Li, Ming-Da Wang, Lun Lu, et al.
Oncotarget|January 27, 2018
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patientsChun-Nan Yeh, Yu-Chan Chang, Yeu Su, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapyKien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
Oncotarget|November 18, 2015
A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancerRunze Jiang, Yi-Tsung Lu, Hao Ho, et al.
Nature Genetics|March 8, 2011
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han populationFan Wang, Cheng-Qi Xu, Qing He, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Journal for Immunotherapy of Cancer|January 27, 2025
Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinomaShin-Yi Chung, Yi-Chen Yeh, Chien-Jung Huang, et al.
Frontiers in Oncology|July 28, 2023
Prognostication and optimal criteria of circumferential margin involvement for esophageal cancer after chemoradiation and esophagectomyAnkit Potdar, Ke-Cheng Chen, Shuenn-Wen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2014
miR-409-3p/-5p promotes tumorigenesis, epithelial-to-mesenchymal transition, and bone metastasis of human prostate cancerSajni Josson, Murali Gururajan, Peizhen Hu, et al.
Stem Cell Research & Therapy|April 2, 2024
Manufacturing, quality control, and GLP-grade preclinical study of nebulized allogenic adipose mesenchymal stromal cells-derived extracellular vesiclesJing Wang, Zhong-Jin Chen, Ze-Yi Zhang, et al.
Hepatology International|September 6, 2019
Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysisChao Li, Ming-Da Wang, Lun Lu, et al.
Oncotarget|January 27, 2018
Identification of MALT1 as both a prognostic factor and a potential therapeutic target of regorafenib in cholangiocarcinoma patientsChun-Nan Yeh, Yu-Chan Chang, Yeu Su, et al.
Journal for Immunotherapy of Cancer|April 3, 2020
<i>PRKDC</i>: new biomarker and drug target for checkpoint blockade immunotherapyKien Thiam Tan, Chun-Nan Yeh, Yu-Chan Chang, et al.
Oncotarget|November 18, 2015
A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancerRunze Jiang, Yi-Tsung Lu, Hao Ho, et al.
Nature Genetics|March 8, 2011
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han populationFan Wang, Cheng-Qi Xu, Qing He, et al.
Pageof 18